Why so many doses, and why now?

Why so many doses, and why now?

Saved in:

Bibliographic Details
Main Authors:	S Bilgic, B Akovalı
Format:	Article
Language:	English
Published:	Bioscientifica 2025-06-01
Series:	European Thyroid Journal
Subjects:	children and adolescents differentiated thyroid carcinoma dosimetry radioactive iodine therapy
Online Access:	https://etj.bioscientifica.com/view/journals/etj/14/3/ETJ-25-0115.xml
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group
by: Michaela Kuhlen, et al.
Published: (2025-08-01)

Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis
by: Michaela Kuhlen, et al.
Published: (2025-02-01)

Response to letter: ‘why so many doses, and why now?’
by: Michaela Kuhlen, et al.
Published: (2025-06-01)

LENVATINIB IN TREATMENT OF RADIOACTIVE IODINE-REFRACTORY WELL-DIFFERENTIATED THYROID CARCINOMA
by: I. S. Romanov, et al.
Published: (2017-06-01)

Radioactive 131Iodine body burden and blood dose estimates in treatment for differentiated thyroid cancer by external probe counting
by: Ramamoorthy Ravichandran, et al.
Published: (2016-07-01)

Clinical experience in using lenvatinib in patients with progressive, radioactive iodine-refractory differentiated thyroid cancer
by: P. A. Isaev, et al.
Published: (2016-06-01)

Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?
by: Justin Benjamin, et al.
Published: (2019-01-01)

Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer?
by: Justin Benjamin, et al.
Published: (2019-04-01)

REFRACTORY OF WELL-DIFFERENTIATED THYROID CANCER TO THE TREATMENT WITH RADIOACTIVE IODINE
by: P. O. Rumyantsev
Published: (2015-04-01)

Applicability of Adults 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines for Postoperative Risk Stratification and Postradioiodine Treatment Dynamic Risk Stratification in Pediatric Population
by: Shashank Shekhar Singh, et al.
Published: (2022-06-01)

Prevalence of Distant Metastases in Whole-Body Scan after Iodine Therapy in Low- and Intermediate-Risk Differentiated Thyroid Cancers
by: A Gholami, et al.
Published: (2024-03-01)

Risk factors and clinical characteristics associated with post-radioactive iodine thyroid storm
by: Harold Henrison C. Chiu, et al.
Published: (2024-12-01)

Clinical outcome and influencing factors of differentiated thyroid cancer patients with radioiodine-refractory lung metastasis
by: Congcong Wang, et al.
Published: (2025-08-01)

Development and validation of a nomogram to predict failure of initial radioactive iodine therapy in differentiated thyroid cancer: a retrospective cohort study
by: Yulong Tang, et al.
Published: (2025-08-01)

Adjuvant treatments for locally advanced differentiated thyroid cancer: a nationwide survey in Japan
by: Terufumi Kawamoto, et al.
Published: (2023-10-01)

POSTRADIAL SIALOZOADENITIS IN PATIENTS WITH PAPILLARY CARCINOMA OF THE THYROID GLAND
by: V. A. Kovalenko, et al.
Published: (2015-02-01)

Medium- and long-term recurrence after radioiodine therapy for differentiated thyroid carcinoma with recombinant human thyrotropin: a meta-analysis
by: Qixian Yao, et al.
Published: (2024-12-01)

COURSE OF PAPILLARY THYROID CARCINOMA DIAGNOSED IN CHILDHOOD AND ADOLESCENCE AND FOLLOWED THROUGH ADULTHOOD: EXPERIENCE FROM A TERTIARY REFERRAL CENTER
by: Hülya Hacışahinoğulları, et al.
Published: (2023-10-01)

Tracheal nodularity and paratracheal soft tissue nodule: post-radioactive iodine treatment changes with peculiar visual and pathologic findings in a case of metastatic follicular variant papillary thyroid carcinoma: a case report
by: Benjamin L. Sievers, et al.
Published: (2025-03-01)

Perception of health and illness and quality of life after total thyroidectomy for differentiated thyroid carcinoma: the PERSAM study
by: Elena Groff, et al.
Published: (2024-12-01)

The assessment of radio-adaptive response in graves' hyperthyroidism patients following radioactive iodine uptake
by: Zahra Fazeli, et al.
Published: (2018-10-01)

Differentiated thyroid carcinoma in children: Clinical characteristics and long-term follow-up
by: Muge Tamam, et al.
Published: (2020-01-01)

Visualization Analysis of Research Hotspots and Trends in Treatment of Radioactive Iodine Refractory Differentiated Thyroid Carcinoma
by: Xiaoxian ZENG, et al.
Published: (2025-02-01)

Impact of positive lymph nodes and RAI therapy on survival in N1b papillary thyroid carcinoma
by: Jie Jian, et al.
Published: (2025-05-01)

The effect of retinoic acid in the ability of cold solid thyroid nodule to take up radioactive iodine: A preliminary study
by: Andreas Lim, et al.
Published: (2019-07-01)

Progress and prospect on treatment for radioiodine-refractory thyroid cancer
by: GENG Qianqian, YANG Aimin
Published: (2025-01-01)

Survival analysis of patients with advanced metastatic differentiated thyroid cancer
by: E. V. Borodavina, et al.
Published: (2022-08-01)

Systemic Immune-Inflammation Index and Systemic Inflammation Response Index Predict the Response to Radioiodine Therapy for Differentiated Thyroid Cancer
by: Wang Y, et al.
Published: (2024-11-01)

Systemic Immune-Inflammation Index and Systemic Inflammation Response Index Predict the Response to Radioiodine Therapy for Differentiated Thyroid Cancer [Corrigendum]
by: Wang Y, et al.
Published: (2025-07-01)

Characteristics of exposure to radioactive iodine during a nuclear incident
by: Zaletel Katja, et al.
Published: (2024-10-01)

Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada
by: Ralf Paschke, et al.
Published: (2025-06-01)

Pilot study of ultrasound-guided microwave ablation for inactivating excess remnant thyroid after surgery in patients with differentiated thyroid cancer
by: Yihao Chen, et al.
Published: (2025-03-01)

New-generation mutitargeted tyrosine kinase inhibitors in the treatment of radioactive iodine-refractory differentiated thyroid cancer
by: A. M. Mudunov
Published: (2015-06-01)

The incidence of hypothyroidism following the radioactive iodine treatment of graves' disease and the predictive factors influencing its development
by: Maha Husseni
Published: (2016-01-01)

Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach
by: Kiyomi Horiuchi, et al.
Published: (2025-07-01)

Long-term outcomes after a radioactive iodine treatment for a single autonomous functioning thyroid nodule in Japan
by: Ai Yoshihara, et al.
Published: (2025-05-01)

Pure red-cell aplasia after radioactive iodine treatment in a patient with papillary thyroid cancer and follow up for two years: a case report
by: Rui Li, et al.
Published: (2025-06-01)

Determining the best dose of lithium carbonate as adjuvant therapy to radioactive iodine for the treatment of hyperthyroidism: a systematic review and meta-analysis
by: Mohamed Abd-ElGawad, et al.
Published: (2025-05-01)

[18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer
by: Arnoldo Piccardo, et al.
Published: (2025-02-01)

An evaluation of deviation from the international atomic energy agency-international commission on radiological protection proposed equation for calculation of radiation dose rate emanating from the patients with differentiated thyroid cancer undergoing radioiodine (I-131) therapy
by: Forough Dehkordi, et al.
Published: (2017-04-01)